艰难梭菌感染的诊断及治疗研究进展
作者:
作者单位:

作者简介:

任南, 黄勇

通讯作者:

中图分类号:

R378.8

基金项目:

国家自然科学基金面上项目(81473123)


Advances in diagnosis and treatment of Clostridium difficile infection
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 文章评论
    摘要:

    艰难梭菌是一种革兰阳性厌氧芽孢杆菌,现已成为全球分布的主要肠道病原体。艰难梭菌感染(Clostridium difficile infection,CDI)可引起抗菌药物相关性腹泻,而其严重感染会导致假膜性结肠炎和中毒性巨结肠等严重并发症。CDI正成为全世界公共卫生的一个持续挑战。本文就近年来国内外CDI的诊断、预防和治疗予以简要综述,为防治CDI提供依据。

    Abstract:

    Clostridium difficile (C. difficile) is a gram-positive anaerobic bacillus and has become a major intestinal pathogen worldwide. C. difficile infection (CDI) can cause antimicrobial-associated diarrhea, severe infection may lead to severe complications such as pseudomembranous colitis and toxic megacolon. CDI is becoming a continuing challenge to public health worldwide. In this paper, the diagnosis, prevention and treatment of CDI at home and abroad in recent years are briefly reviewed, so as to provide a basis for the prevention and treatment of CDI.

    参考文献
    相似文献
引用本文

季欣欣, 孟秀娟, 任南,等.艰难梭菌感染的诊断及治疗研究进展[J]. 中国感染控制杂志,2019,18(6):600-606. DOI:10.12138/j. issn.1671-9638.20195349.
JI Xin-xin, MENG Xiu-juan, REN Nan, et al. Advances in diagnosis and treatment of Clostridium difficile infection[J]. Chin J Infect Control, 2019,18(6):600-606. DOI:10.12138/j. issn.1671-9638.20195349.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2019-04-25
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-06-28
  • 出版日期: